Long non-coding RNA LINC00346 contributes to cisplatin resistance in nasopharyngeal carcinoma by repressing miR-342-5p

Cui, ZQ; Pu, T; Zhang, YJ; Wang, J; Zhao, YL

Zhao, YL (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Rhinol, 1 Jianshe East Rd, Zhengzhou 450052, Henan, Peoples R China.

OPEN BIOLOGY, 2020; 10 (5):

Abstract

Cisplatin has been used as the first-line chemotherapy to treat advanced nasopharyngeal carcinoma (NPC), while acquired cisplatin resistance resulting......

Full Text Link